Bicara Therapeutics Statistics

Total Valuation

BCAX has a market cap or net worth of $900.58 million. The enterprise value is $380.27 million.

Market Cap	900.58M
Enterprise Value	380.27M

Important Dates

The next estimated earnings date is Tuesday, March 18, 2025, before market open.

Earnings Date	Mar 18, 2025
Ex-Dividend Date	n/a

Share Statistics

BCAX has 54.42 million shares outstanding. The number of shares has increased by 666.34% in one year.

Current Share Class	54.42M
Shares Outstanding	54.42M
Shares Change (YoY)	+666.34%
Shares Change (QoQ)	+1,308.39%
Owned by Insiders (%)	1.57%
Owned by Institutions (%)	59.09%
Float	31.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.77
P/TBV Ratio	1.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 36.01, with a Debt / Equity ratio of 0.00.

Current Ratio	36.01
Quick Ratio	35.96
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-13.62%
Revenue Per Employee	n/a
Profits Per Employee	-$1.86M
Employee Count	32
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BCAX has paid $6,000 in taxes.

Income Tax	6,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	13.87
200-Day Moving Average	n/a
Relative Strength Index (RSI)	69.80
Average Volume (20 Days)	379,221

Short Selling Information

The latest short interest is 4.17 million, so 7.66% of the outstanding shares have been sold short.

Short Interest	4.17M
Short Previous Month	4.08M
Short % of Shares Out	7.66%
Short % of Float	13.31%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-69.44M
Pretax Income	-64.84M
Net Income	-59.48M
EBITDA	-69.38M
EBIT	-69.44M
Earnings Per Share (EPS)	-$18.09

Full Income Statement

Balance Sheet

The company has $520.76 million in cash and $445,000 in debt, giving a net cash position of $520.31 million or $9.56 per share.

Cash & Cash Equivalents	520.76M
Total Debt	445,000
Net Cash	520.31M
Net Cash Per Share	$9.56
Equity (Book Value)	509.56M
Book Value Per Share	9.37
Working Capital	507.03M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$52.76 million and capital expenditures -$467,000, giving a free cash flow of -$53.22 million.

Operating Cash Flow	-52.76M
Capital Expenditures	-467,000
Free Cash Flow	-53.22M
FCF Per Share	-$0.98

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCAX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-666.34%
Shareholder Yield	n/a
Earnings Yield	-6.60%
FCF Yield	-5.91%

Analyst Forecast

The average price target for BCAX is $39.50, which is 138.67% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$39.50
Price Target Difference	138.67%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2